Compare ADMA Biologics Inc (ADMA) vs Kinder Morgan Inc (KMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Kinder Morgan Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Kinder Morgan Inc trades at $31.59 (market cap $70.10B). The key difference: Kinder Morgan Inc is far larger — about 31.6× ADMA Biologics Inc's market cap, and Kinder Morgan Inc pays a 3.75% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | KMI | |
|---|---|---|
Market Cap | $2.22B | $70.10B |
Sector | Health | Energy |
52-Week High | $20.38 | $34.31 |
52-Week Low | $7.60 | $25.84 |
Enterprise Value | $2.29B | $102.15B |
Dividend Yield | — | 3.75% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →
